Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

Antibiotic stocks.... Many tears have been shed

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
nferna Member Profile
 
Followed By 1
Posts 210
Boards Moderated 0
Alias Born 12/07/13
160x600 placeholder
Aurinia falls 28% amid mixed shelf offering, skepticism on buyout rumors Seeking Alpha - 11/22/2021 12:43:00 PM
Aurinia Pharmaceuticals drops 12% after filing mixed shelf offering Seeking Alpha - 11/19/2021 5:26:12 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 11/19/2021 5:05:35 PM
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Business Wire - 11/10/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2021 4:21:48 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/3/2021 4:14:03 PM
Aurinia Pharma slips as uptake of lupus nephritis therapy slows Seeking Alpha - 11/3/2021 8:28:18 AM
Aurinia Pharma EPS misses by $0.06, beats on revenue Seeking Alpha - 11/3/2021 6:11:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2021 6:02:00 AM
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates Business Wire - 11/3/2021 6:00:00 AM
Aurinia Pharma Q3 2021 Earnings Preview Seeking Alpha - 11/2/2021 11:59:17 AM
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis Business Wire - 11/1/2021 10:12:00 AM
Aurinia Pharma drops after GlaxoSmithKline denies report on potential bid Seeking Alpha - 11/1/2021 10:01:23 AM
Aurinia Pharma may be worth $45-$53/share in a potential sale - analyst Seeking Alpha - 10/29/2021 10:14:43 AM
Aurinia Pharmaceuticals gains on speculation of other potential bidder interest Seeking Alpha - 10/28/2021 10:19:31 AM
Oppenheimer cuts Aurinia to perform on M&A chatter, recent share price rise Seeking Alpha - 10/28/2021 9:26:15 AM
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Business Wire - 10/27/2021 7:07:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2021 4:34:01 PM
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Business Wire - 10/26/2021 4:10:00 PM
Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest Dow Jones News - 10/25/2021 9:25:00 AM
EDIT, AUPH and DWAC among after hours Seeking Alpha - 10/22/2021 5:21:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/22/2021 4:31:38 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/17/2021 4:04:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 5:02:32 PM
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire - 9/15/2021 1:11:00 PM
nferna   Wednesday, 12/16/20 01:11:28 PM
Re: None
Post # of 14369 
Antibiotic stocks.... Many tears have been shed over these. Noble cause, bad investment. See

NBRV
TTPH
AKAO
CEMP
ETTX
Probably more...

They all think they will be the next Cubist.

Denner is no dummy, at least ITRM has that going for them. Still, not touching it

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences